Get the app
Yvonne Greenstreet
CEO of Alnylam Pharmaceuticals, a pioneering biopharmaceutical company focused on RNA interference therapeutics. She has over 25 years of experience in the biopharma industry and a global background from London to Ghana.
Best podcasts with Yvonne Greenstreet
Ranked by the Snipd community
11 snips
May 29, 2025
• 31min
Alnylam’s Yvonne Greenstreet on RNAi and a ‘golden era’ in biotech
chevron_right
Yvonne Greenstreet, CEO of Alnylam Pharmaceuticals, has over 25 years of biopharma experience and is a leader in RNA interference therapeutics. She discusses the transformative power of RNAi technology and highlights the approval of six new medicines in just six years. Greenstreet shares her vision for biotech, emphasizing a patient-focused, teamwork-oriented culture and the importance of diversity in leadership. She also reflects on her career journey, emphasizing mentorship’s role in developing future leaders and fostering innovation in the industry.
The AI-powered Podcast Player
Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
Get the app